Nanxiang Ge
About Nanxiang Ge
Nanxiang Ge serves as the Vice President and Head of Biometrics and Data Management at Roivant Sciences, bringing extensive experience in biostatistics and data management within the pharmaceuticals sector.
Current Role at Roivant Sciences
Nanxiang Ge serves as the Vice President and Head of Biometrics and Data Management at Roivant Sciences. He has held this position since 2021, contributing to the company's initiatives in biometrics within the pharmaceutical sector. His role involves overseeing data management processes and ensuring the integrity of biometrics data used in drug development and regulatory submissions.
Previous Experience in Biostatistics
Before joining Roivant Sciences, Nanxiang Ge worked at Bristol Myers Squibb as the Global Head of Hematology Biostatistics for a period of 10 months in 2020 to 2021. Prior to that, he served as the Executive Director of Late Phase Biostatistics at Celgene from 2018 to 2020, focusing on hematology and oncology. His career also includes a 12-year tenure at Daiichi Sankyo, Inc. as Senior Director of Oncology Biostatistics.
Educational Background
Nanxiang Ge earned his Ph.D. in Statistics from the University of Illinois Urbana-Champaign, where he studied from 1991 to 1995. He also holds a Bachelor's degree in Applied Mathematics from the University of Science and Technology of China, which he completed from 1983 to 1988. His educational background provides a strong foundation for his expertise in biometrics and data management.
Expertise in Biometrics and Drug Development
Nanxiang Ge possesses extensive experience in biometrics, particularly in the context of drug discovery and development. He has a demonstrated history of growing and developing global biometrics organizations within the pharmaceutical industry. His expertise includes regulatory submissions and post-marketing phases, making him a valuable asset in the field.